CASP1 and myeloid sarcoma: Thus: (1) caspase-1, IL-1β, and IL-18 upregulation was shown to associate with the progression and severity of disease (17–19); and (2) caspase-1 expression was observed to be elevated in MS plaques (20) and in peripheral mononuclear cells of MS patients (19).